Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Collaborative Health Research Projects (NSERC partnered)

University of Toronto

$149,788.00

Platform technology for maturation of human stem cell derived cardiomyocytes and cardiotoxicity screening

FY 2015-16

Summary
Beating heart cell cannot be sampled and expanded from human hearts, thus pharmaceutical industry is forced to use alternative methods to assess safety and efficacy of new drug candidates before they reach humans including assessment in animal models. Animal heart cells have different functional properties than human heart cells, thus it is not possible to fully capture both positive and negative effects of a drug during pre-clinical testing. As a result, many promising drug candidates are abandoned early on and some dangerous drugs reach human use e.g. Vioxx that resulted in ~30,000 deaths and $5billion in settlements. This project will revolutionize the way drugs are tested before they reach humans by developing an array of human heart tissues, starting from stem cells. We will mature the tissues so that they resemble adult human heart using electrical field stimulation. We will engineer a fully inert platform that does not absorb or interact with the applied drugs. It will also be compatible with the equipment already in use in pharmaceutical and biological labs. Uniquely, our platform will give readouts of many cardiac responses at once from the single tissue in a non-destructive manner. By looking at this integrated response from a real mature human heart tissue, we will make drug discovery process more effective ultimately saving cost to Canadian pharmaceutical industry and lives of Canadians by enabling discovery of safer and more effective drugs.
Program
Collaborative Health Research Projects (NSERC partnered)
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
336760
Name
Radisic Milica
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Natural Sciences and Engineering Research Council of Canada (NSERC)
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Collaborative Health Research Projects - NSERC Partnered
Projecttitle
Platform technology for maturation of human stem cell derived cardiomyocytes and cardiotoxicity screening
Programtype2
Operating Grants
Orgnameinp2
University of Toronto
Cihramount2
$149,788
Cihrequipment2
$0
Programname2
Collaborative Health Research Projects (NSERC partnered)
Keyworddelim
Cardiotoxicity; Contraction; Drug; Heart; Mapping; Microfabrication; Myocardium; Pluripotent Stem Cells; Tissue; Tissue Engineering
Abstract
Beating heart cell cannot be sampled and expanded from human hearts, thus pharmaceutical industry is forced to use alternative methods to assess safety and efficacy of new drug candidates before they reach humans including assessment in animal models. Animal heart cells have different functional properties than human heart cells, thus it is not possible to fully capture both positive and negative effects of a drug during pre-clinical testing. As a result, many promising drug candidates are abandoned early on and some dangerous drugs reach human use e.g. Vioxx that resulted in ~30,000 deaths and $5billion in settlements. This project will revolutionize the way drugs are tested before they reach humans by developing an array of human heart tissues, starting from stem cells. We will mature the tissues so that they resemble adult human heart using electrical field stimulation. We will engineer a fully inert platform that does not absorb or interact with the applied drugs. It will also be compatible with the equipment already in use in pharmaceutical and biological labs. Uniquely, our platform will give readouts of many cardiac responses at once from the single tissue in a non-destructive manner. By looking at this integrated response from a real mature human heart tissue, we will make drug discovery process more effective ultimately saving cost to Canadian pharmaceutical industry and lives of Canadians by enabling discovery of safer and more effective drugs.
Competitiondate
201510
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Radisic, Milica; Nanthakumar, Kumaraswamy
Approvedterm
3 ans 0 mois
Cihrcontribution2
Major Initiatives #2~ $149,788~ $0~
University of Toronto - $149,788 Grant (2015-16) | Canada Spends